Protara Therapeutics Inc (TARA)
Healthcare
Biotechnology
3.90 $
-2.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Protara Therapeutics Inc (TARA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 88.1% of the shares are freely tradable; institutional investors hold 82.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
82.4%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
2.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
88.1%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
8.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
56Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| HHG PLC | 9.26 | 5,207,011 | +1.3 | 03/31/2026 |
| BlackRock Inc | 6.04 | 3,394,968 | +40.9 | 03/31/2026 |
| Velan Capital Investment Management LP | 5.04 | 2,834,652 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 5.04 | 2,831,208 | +275.8 | 03/31/2026 |
| Vanguard Group Inc | 4.26 | 2,391,903 | +25.6 | 12/31/2025 |
| Blackstone Inc | 4.03 | 2,265,514 | +18.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.77 | 2,119,018 | +0.0 | 03/31/2026 |
| Sio Capital Management, LLC | 3.50 | 1,969,839 | +14.8 | 03/31/2026 |
| Integral Health Asset Management, LLC | 3.11 | 1,750,000 | -22.2 | 03/31/2026 |
| AIGH Capital Management, LLC | 2.89 | 1,622,733 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.